By Jeff Sistrunk ( April 14, 2014, 8:24 PM EDT) -- The Federal Trade Commission on Monday approved Akorn Inc.'s $640 million acquisition of Long Island, N.Y.-based Hi-Tech Pharmacal Co. Inc. on the condition that the pharmaceutical companies sell five generic prescription drug lines to an Actavis PLC unit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.